The pharmaceutical companies Biogen and Eisai last week announced that a monoclonal antibody treatment reduced cognitive decline by 27% in people with early stage Alzheimer’s compared with those on a placebo after 18 months. www.science.org/content/article/news-glance-ai-regulation-renewable-energy-and-alzheimer-s-therapy? Lecanemab belongs to a class...

The number of COVID-related deaths in England and Wales increased by nearly 40% in a week and reached their highest number since August. The latest data from the Office for National Statistics (ONS) shows some 400 deaths registered in...